Today, we announced the appointment of Beth A. Krewson as Head of Legal at PharmaEssentia. In her new role, Beth will be responsible for the legal and compliance strategy to advance our leadership in MPNs and other hematological diseases. Learn more: https://bit.ly/4cNctAg
關於我們
PharmaEssentia Corporation, based in Taipei, Taiwan, is a rapidly growing, fully integrated global biopharmaceutical innovator. Leveraging proven scientific principles and deep expertise in commercializing medicines, the company aims to deliver biologics for challenging diseases in hematology, oncology and immunology, with one approved product and a diversifying pipeline. Founded in 2003, the company is now expanding its global presence with operations in the U.S., Japan, China and Korea. See our community guidelines: http://bit.ly/3RpFpn3
- 網站
-
http://www.pharmaessentia.com
外部PharmaEssentia連結
- 產業
- 生物技術研究
- 公司規模
- 201-500 名員工
- 總部
- Nangang DistrictTaipei
- 類型
- 上市公司
- 創立時間
- 2003
- 專長
- Biologics、Oncology、Rare Disease、Orphan Drugs、Orphan Disease、Drug Development、Pharmaceuticals和Hematology
地點
PharmaEssentia員工
動態消息
-
Know the facts about polycythemia vera (PV) and learn more about our focus on providing new therapeutic options for patients with #MPNs: https://lnkd.in/gMqBgEXg
-
In the latest episode of “PV Pod: Stories from the Marrow,” Dr. Douglas Tremblay from Mount Sinai School of Medicine discusses #PolycythemiaVera (PV) progression and the challenges in predicting and preventing this #RareDisease. Listen to PV Pod here: https://lnkd.in/eE99jZqv
-
Today, we announced the promotion of Robert B Geller, MD to General Manager. Dr. Geller will be responsible for expanding our pipeline and partnerships and capabilities in the U.S. to advance therapeutic options and care for patients. https://lnkd.in/ep6P_S5T
-
Know the facts about polycythemia vera (PV) and learn more about our focus on providing new therapeutic options for patients with #MPNs: https://bit.ly/40TXfDh
-
PharmaEssentia has completed patient enrollment for our Phase 2b EXCEED-ET trial and Phase 3b ECLIPSE-PV trial. Learn more: https://lnkd.in/dsjfKsk9 #PolycythemiaVera #EssentialThrombocythemia
-
Today, we announced the appointment of Fred P. as Head of Commercial at PharmaEssentia. In his new role, Fred will lead the commercial teams, including sales, marketing, and analytics. Learn more: https://lnkd.in/eqrGW-68
-
This #Juneteenth, join us in commemorating the anniversary of the effective end of slavery in the U.S. At PharmaEssentia, we reflect on how we can foster inclusivity in our culture — both in the workplace and outside of it — and hope this day inspires others to do the same.